Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0000899243-20-030860)

Filing Details

Accession Number:
0000899243-20-030860
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 17:54:39
Reporting Period:
2020-11-09
Accepted Time:
2020-11-12 17:54:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1805387 Cerevel Therapeutics Holdings Inc. CERE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578965 Adam Koppel C/O Bain Capital Life Sciences Investors
200 Clarendon Street
Boston MA 02116		 Yes No Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-09 332,293 $10.30 60,632,356 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Footnotes
  1. On November 9, 2020, BC Perception Holdings, LP ("BC Perception") purchased 332,293 shares of the Issuer's Common Stock at a price of $10.30 per share.
  2. Adam Koppel is a Managing Director of Bain Capital Life Sciences Investors, LLC, which is the ultimate general partner of Bain Capital Life Sciences Fund, LP. As a result, Dr. Koppel may be deemed to share voting and dispositive power with respect to the securities held by BC Perception. Dr. Koppel disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.